Bramox is indicated when other forms of treatment are inadequate and corrective factors have been ruled out.
Midodrine is a prodrug of desglymidodrine, a sympathomimetic agent that stimulates peripheral α1-aderenergic receptors to cause vasoconstriction and raise peripheral arterial resistance, leading to an increase in arterial blood pressure.
Bramox is available in 2.5mg and 5mg tablets. Initially patients should be prescribed 2.5mg three times daily which may be increased weekly, depending on blood pressure readings, up to a maintenance dose of 10mg three times daily. The last dose should be taken at least 4 hours before bedtime to reduce the risk of supine hypertension.
The most frequent adverse effects of midodrine are piloerection, pruritus of the scalp and dysuria.